OncLive
Jeffrey Zonder, M.D., hematologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team and member of the Hematology Oncology Multidisciplinary Team at Karmanos, discussed the results of the phase 3 PERSEUS trial with OncLive TV. The findings from the investigation were presented at the 2023 American Society of Hematology Annual Meeting.
Watch here.